









































Accumulation of DNA damage, if not repaired, can lead 
to premature aging, as indicated by several inherited 
diseases caused by mutations of DNA damage response 
factors that show features of premature aging [1], [2]. 
Furthermore, increased exposure to DNA damage might 
lead to the development of premature aging 
characteristics, e.g. in long-term survivors of 
chemotherapy, for which we proposed to use the term 













































One of the proteins orchestrating DNA damage 
response is ATM (ataxia telangiectasia mutated), which 
plays a central and multiple role in the cellular stress 
response by monitoring and maintaining DNA integrity 
(reviewed by [4]). These crucial functions are mirrored 
by the disorder caused by its mutations, Ataxia 
telangiectasia (A-T), which is also classified as a 
segmental progeroid syndrome [5] and includes 
symptoms like cerebellar degeneration, immuno-
deficency, genomic instability, thymic and gonadal 
atrophy and cancer predisposition [6]. 
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cell cycle in response to DNA damage. This is exerted 
by ATM-dependent induction of p53 that leads to 
activation of the CDK inhibitor p21, resulting in 
inhibition of the Cyclin-E/CDK2 complex and 
inhibition of progression from G1 into S-phase [7].as 
well as a CHK2 phsophorylation dependent G2/M arrest 
[8]. 
 
An equally important function of ATM is in effectively 
repairing DNA double-strand breaks. Upon DNA 
damage, ATM is auto-phosphorylated leading to 
dissociation of the inactive dimer to active monomers, 
which are rapidly recruited to DNA DSB sites together 
with the MRN (Mre11, Rad50, NBS1) complex 
(reviewed by [4]. Then, ATM phosphorylates the 
histone variant H2AX to γH2AX, which provides a 
docking station for many repair factors and signal 
transducers like p53 and BRCA1, which are in turn 
phosphorylated by ATM [9, 10]. In addition, ATM 
activity on DNA DSB sites enables the relaxation of 
heterochromatin, which facilitates access of repair 
proteins to the damaged DNA [11].  
 
A more recently identified function of ATM has been 
observed in the response to oxidative stress [12], 
probably by sensing reactive oxygen species (ROS) 
[13]. ROS impact on signal transduction, 
aging/senescence, apoptosis, neuromodulation and 
antioxidant gene modulation, in addition atherosclerosis 
and several neurodegenerative diseases [14], and at least 
part of these effects might involve ATM, as oxidative 
stress response pathways are constitutively active in A-
T cells [13, 15].  
 
Finally, a link between ATM and the pentose phosphate 
pathway is established (PPP, reviewed in [16]. After 
DNA damage, ATM stimulates PPP in order to generate 
nucleotides and NADPH needed for DNA repair. 
NADPH thereby not only provides the reducing 
equivalents for biosynthetic reactions but also for 
regeneration of the major ROS scavenger glutathione 
[17].  
 
Recently, a consensus phosphorylation motif recognized 
by ATM and ATR (ATM and Rad3-related; a kinase 
that shares many substrates with ATM, but responds to 
distinct types of DNA damage) was identified [18].  
 
To our surprise, the published consensus site is present 
in the amino acid sequence of SNEV
hPrp19/hPso4  (for 
simplicity reasons termed SNEV in the following), a 
“multi-talented” protein involved in pre-mRNA splicing 
[19-22], DNA repair [23-25], senescence and extension 
of life span [26, 27] and neuronal differentiation [28, 
29]. SNEV increases replicative resistance to oxidative 
stress, reduces basal levels of DNA damage and 
apoptosis and increases cellular life span in vitro [26]. 
The role of SNEV in the mammalian DNA damage 
response (DDR) first emerged with the report that it was 
strongly upregulated by DNA damage in human cells, 
and that its depletion by siRNA resulted in an 
accumulation of double-strand breaks (DSBs), apoptosis 
and reduced survival after exposure to ionizing 
radiation [23]. Subsequently, Zhang and collaborators 
(2005) have shown that Cdc5L, a member of the SNEV 
core complex together with PLRG1 and SPF27/BCAS2, 
directly interacted with the Werner syndrome protein 
(WRN) and is involved in early steps of DNA 
interstrand cross link (ICL) repair. WRN is a DNA 
helicase that has roles in homologous recombination 
and the processing of stalled replication forks in 
response to DNA damage. Mutations of WRN are the 
cause of Werner’s syndrome, one of the segmental 
progeroid syndromes that most strikingly resemble 
aging (reviewed by [30]. DNA damage also induces the 
attachment of ubiquitin to a subfraction of endogenous 
SNEV via a thiolester linkage, and this modification 
disrupts the interaction between SNEV and both Cdc5L 
and PLRG1 demonstrating that DNA damage can 
profoundly affect the structure of the SNEV core 
complex [24]. Recently, the SNEV complex has been 
connected to DNA damage checkpoint signaling 
pathways. Cdc5L interacts physically with the cell-
cycle checkpoint kinase ataxia-telangiectasia and Rad3-
related (ATR). Depletion of Cdc5L by RNA-mediated 
interference methods results in a defective S-phase cell-
cycle checkpoint and cellular sensitivity in response to 
replication-fork blocking agents [31].  
 
While mutations and deletions of several DNA repair 
factors are known to cause progeroid syndromes, there 
is very little known on the effects of overexpressing 
DNA repair factors on the life spans of model systems. 
As SNEV is known to extend the replicative life span of 
normal human cells, it would be of some interest to see 
if this effect is due to its DNA repair function. 
 
Here, we show that indeed SNEV
 is phosphorylated in 
response to oxidative stress and different DNA 
damaging agents, and that phosphoSNEV is located 
predominantly in the nucleus. Moreover, we examined 
the impact of the phosphorylation on repair capacity 
and life span in cultured human cells by 
overexoressing wt and phosphorylation incompetent 
SNEV
  and show that phosphorylation at S149 is 
essential for mediating the cytoprotective effect of 
SNEV
  upon DNA damage/oxidative stress and 
partially contributes to the life span extension caused 
by SNEV overexpression. 
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Oxidative stress induces an additional SNEV protein 
band in Western blotting 
 
From previous results we know that SNEV
 expression is 
induced upon oxidative and DNA DSB damage [23, 
26]. To further study the effect of oxidative stress on 
SNEV, we treated HeLa cells with 1mM hydrogen 
peroxide for different times and detected additional 
bands above the expected 56 kDa band in a Western 
Blot with anti-SNEV antibody, and band intensity 
increased in a time-dependent manner. These higher 
bands were removed after dephosphorylation using calf 
intestinal phosphatase (Fig. 1A). Similarly, this 
additional SNEV
 band appeared when we treated human 







































These results prompted us to ask if these bands might 
represent a phosphorylated form of SNEV in response 
to oxidative stress. Therefore, we isolated SNEV as 
GFP-fusion from stable HeLa cells constitutively 
expressing GFP-tagged SNEV
 under the control of the 
endogenous promoter as described in [32] and 
submitted it to mass spectrometric analysis. The 
advantage of using GFP-SNEV-Hela lies in allowing 
the use of a commercially available GFP-antibody for 
IP which is covalently coupled to agarose beads, thus 
avoiding predominant detection of immunglobulins in 
the mass spectrometric analysis. In order to make sure 
that GFP-SNEV behaves similarly to SNEV in cells we 
confirmed its localization to nuclei (Fig. S1A) as well as 
its ability to integrate into the SNEV/CDC5L complex 
by co-precipitation of SNEV and CDC5L with GFP-







































Figure  1.  Upon  oxidative  stress,  SNEV  is 
detected as double band, probably representing 
a  phosphorylated  species.  (A)  Upon  treatment 
with  hydrogen  peroxide,  additional  bands  of  higher 
molecular  weight  were  detected  with  anti‐SNEV 
antibody. These bands disappear upon incubation with 
phosphatase. (B) Similarly, upon bleomycin treatment 
of  fibroblasts,  we  detected  an  additional  band  with 
anti‐SNEV  antibody,  which  increased  in  a  dose‐and 





antibody.  Anti‐ß‐actin  was  used  to  ensure  equal 
loading. Anti‐γH2AX antibody was used to confirm that 
the  treatment  induces  DNA  damage.  (C)  Collision‐
induced  dissociation  spectrum  of  the  SNEV  peptide 
AVPSS(ph)QPSVVGAGEPM(ox)DLGELVGM(ox)TPEIIQKL
3. 
GFP‐SNEV  was  isolated  by  IP  from  stable  GFP‐SNEV 
Hela  treated  with  H2O2.  Phosphopeptides  were 
enriched  by  TiO2  affinity  chromatography  and 





site  on  ATM  substrates  that  are  regulated  by  DNA 
damage  is  conserved  in  the  SNEV
  amino  acid 
sequences  across  different  vertebrates,  but  not  in 
non‐vertebrates. 
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S149 with a probability of 76.5% (Fig. 1C). While the 
consistence of three different spectra with different m/z 
ratios underscores the correct assignment of the 
phosphorylation to this site, the remaining uncertainty 
comes from the presence of 3 serine residues within a 
quite long peptide. Together with the problem of lack of 
trypsin or chymotrypsin proteolytic sites near these 
serines, a better proof of S149 as the really 
phosphorylated serine by mass spectrometry is 
hampered.  
 
Interestingly, S149 also represents an ATM target site 
(Fig. 1D). Fig. S2 shows that the signal detected by MS 
is specific for H2O2-treated cells. This is not due to a 
difference in the efficiency of the IP, since the Western 
Blot in fig. S1B clearly shows that comparable amounts 
of GFP-SNEV were precipitated under both conditions. 
Table S1 gives a list of the identified phosphopeptides 
of SNEV in the H2O2-treated sample with site 
probability calculated by phosphoRS 2.0.  
 
Taken together, the mass spec spectra, the presence of 
an ATM kinase consensus site, and ATM’s known 
function as a kinase signaling oxidative stress prompted 
us to generate an anti-pSNEV(S149) specific antibody. 
 
Phosphorylation of SNEV at S149 is induced by 
oxidative stress in different cell types 
 
In order to take a closer look at this possible 
phosphorylation site of SNEV, a phospho-specific 
antibody was generated. This anti-pSNEV(S149) 
antibody detects a band at the expected size of SNEV
 
upon oxidative stress treatment of Hela cells, and this 
signal is abolished upon phosphatase treatment (Fig. 
2A). Besides the bands at the expected size, other bands 
are as well detected by anti-pSNEV(S149) antibody on 
Western Blot of Hela lysates (Fig. S3), but at higher 
molecular weights. These bands might represent post-
translationally modified SNEV in complexes similar to 
the ones described in [24]. 
 
Based on these results, we were curious to confirm our 
assumption that SNEV phosphorylation was stimulated 
by DNA damage in normal cells. Human diploid 
fibroblasts (HDF5) were exposed to different 
concentrations of hydrogen peroxide for 1 hour or to 
100μM hydrogen peroxide for different times. Total cell 
lysates were subjected to Western Blot analysis with 
anti-pSNEV(S149). Indeed, phosphorylation of SNEV 
was triggered by oxidative stress in a time- and dose-
dependent manner (Fig. 2B and C). Phosphorylation 
was observed as quickly as after 5 minutes of hydrogen 
peroxide treatment and reached a maximum after 1 
hour. To verify that hydrogen peroxide treatment indeed 
induced the formation of DNA double strand breaks 
(DSB), we examined the ATM dependent 
phosphorylation of γH2AX, which occurs in response to 
DSB [7], and showed a similar kinetic as 













































Different types of DNA damage induce nuclear 
localization of pSNEV  
 
In order to localize pSNEV within the cells, we first 
tested for the specificity of the antibody for indirect 
Figure  2.  Phosphorylation  of  SNEV  at  serine  149  is
induced  by  oxidative  stress  in  a  time‐  and  dose
dependent manner. (A) Upon oxidative stress treatment, the
band  detected  by  a  phospho‐SNEV
  specific  antibody  (anti‐
pSNEV(S149))  increases,  and  diminishes  upon  phosphatase
treatment. HeLa cells were treated with 1mM H2O2 for 1h or left
untreated.  Lysates  were  incubated  with  CIP  and  subjected  to
Western  Blotting  with  a  specific  anti‐phosphoSNEV(S149)





Western  Blot  was  detected  with  anti‐pSNEV(S149)  and  anti‐
SNEV  to  compare  pSNEV  to  total  SNEV  levels.  anti‐γH2AX
antibody  was  used  as  positive  control  for  stress‐dependent
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peptide that was used for generation of the antibody or a 
non-phospho-peptide with the same sequence, for pre-
blocking the anti-pSNEV antibody, staining was 
abolished by blocking with the phospho-peptide, while 
no difference was seen after pre-incubation with the 
non-phospho-peptide (Fig. S4).  
 
In addition to a strong and predominant nuclear signal 
upon oxidative stress, the phosphorylated form is also 
detected in the cytoplasm (Fig, 3A), and it is currently 
unclear if this phosphorylation is a signal for shuttling 
of SNEV between nucleus and cytoplasm. In any case, 
under normal conditions only very few cells stained 
positive for phosphoSNEV, which seems to localize to 







































To test if phosphorylation of SNEV
  is restricted to 
oxidative stress conditions or if it is a general step in the 
DNA damage response, we challenged cells with 
mitomycin C (MMC), a potent DNA crosslinker. HeLa 
cells were incubated with 25µg/ml MMC for 24 hours 
and submitted to indirect immunofluorescence staining 
with anti-pSNEV(S149). As observed for hydrogen 
proxide, also MMC induces phosphorylation of SNEV, 
and the phosphorylated species is mainly detected in the 
nucleus (Fig. 3B).  
 
Thus, we assume that the phosphorylation of SNEV
 is 
an integral part of the nuclear DNA damage response. 
 
Phosphorylation of SNEV at serine 149 is ATM-
dependent 
 
In order to test if this phosphorylation is dependent on 
ATM, we took advantage of the reagent 2-(4-
Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one (KU-
55933), a specific inhibitor of ATM kinase activity [33]. 
Indeed, we observed markedly reduced levels of 
phosphorylated SNEV upon oxidative stress, when 
ATM was blocked by Ku-55933. Similarly, upon 
oxidative stress we detected SNEV as a double band 
with anti-SNEV antibody, and Ku-55933 treatment 
abolished the upper band, supporting the idea that this 
upper band represents phosphoSNEV (Fig. 4A). The 
fact that the phosphoSNEV bands did not disappear 
completely could be due to another kinase that backs up 
ATM function. It is known that both ATM and ATR 
can phosphorylate H2AX [34], which also explains that 
H2AX phosphorylation is only slightly reduced upon 
ATM inhibition.  
 
To confirm that ATM controls SNEV S149 
phosphorylation with an independent method, we used 
mouse embryonic fibroblasts in which ATM was 
flanked by loxP sites and cut out using Cre recombinase 
(ATM -/- MEF). As shown in fig. 4B, the induction of 
pSNEV(S149) upon hydrogen peroxide treatment was 
reduced to less than half of that observed in wildtype 
MEF (pSNEV band intensity 0.16 versus 0.38 arbitrary 
units, normalized to ßActin intensity; data not shown). 
The lower panel in fig. 4B shows an agarose gel of the 
genotyping PCR. Using a combination of three primers, 
three different fragments are amplified according which 
cells can be genotyped. The 320 bp fragment indicating 
absence of loxP sites is amplified only in wildtype cells, 
whereas presence of loxP sites gives rise to a 420 bp 
fragment. Only after introduction of Cre recombinase is 
ATM cut out and a fragment of 920 bp is amplified. 
Since the 420 bp fragment is still present inspite of Cre 
transfection, there is still residual ATM activity in our 
ATM -/- MEF, which explains why we still detect some 
Figure 3. Upon oxidative stress, SNEV is phosphorylated
and  localizes  mainly  to  the  nucleus.  (A)  Hela  cells  were
seeded on coverslips and treated with 100 µM H2O2  for 1 hour.
Cells were stained with anti‐pSNEV(S149) and DAPI as described
in  the  Materials  and  Methods  section  and  subjected  to
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wt MEF. 
 
Taken together, this suggests that SNEV is 
phosphorylated upon DNA damage in an ATM-
dependent manner and the presence of the ATM target 
motif suggest that it might be a novel direct substrate 















































Effect of phosphorylation on life span and stress 
resistance in HUVEC 
 
To investigate the physiological effect of the 
phosphorylation at S149 of SNEV, we generated stable 
HUVEC cell lines overexpressing either wildtype 
SNEV (wtSNEV HUVEC) or a point mutant SNEV 
where the ATM target site was abolished by exchanging 
serine 149 for alanine (SNEV S149A HUVEC). Both 
recombinant cell lines showed comparable 
overexpression of SNEV versus untransfected HUVEC 
(Fig. 5A). Overexpression was additionally confirmed 
by IF (Fig. S5).  
 
Using these cell lines, we studied how the lack of 
phosphorylation at S149 affects DNA damage levels, 
stress resistance and life span. 
 
As described earlier [26], overexpression of wtSNEV 
had a strong life-span extending effect. Indeed, SNEV 
wt HUVEC underwent 30 population doublings post 
transduction, while empty vector control HUVEC 
reached senescence already upon PD 8 post 
transduction, thus SNEVwt overexpression more than 
tripled the replicative life span. Surprisingly, SNEV 
S149A overexpression did not fully abrogate this effect 
of SNEV and also extended the replicative life span of 
HUVEC, albeit to a significantly lower extent of around 
18 PD post transduction (Fig. 5B). Replicative 
senescence at the respective replication end points was 
confirmed by staining for the widely accepted 
senescence marker SA ß-galactosidase expression (data 
not shown).  
 
Since we observed phosphorylation of SNEV upon 
treatment with DNA damaging agents, we hypothesized 
that phosphorylation might be necessary to elicit a 
proper DNA damage response. Therefore we performed 
comet assays to test for DNA integrity under basal 
conditions. 
 
Indeed wtSNEV overexpressing cells were mainly 
assigned to categories I or II, corresponding to no or 
low levels of DNA damage. In contrast, the SNEV S149 
HUVEC have lower levels of DNA damage than empty 
vector controls, but still increased damage levels 
compared to wtSNEV HUVEC. We conclude that 
increased SNEV levels lead to increased DNA 
maintenance in unstressed conditions, while the full 
effect of more efficient repair unfolds only if SNEV can 
be phosphorylated at S149.  
 
In addition to the basal levels of DNA damage, we 
assessed the cellular response to treatment with 
genotoxic and/or oxidative stress inducing reagents. 
 
Figure 4. Phosphorylation of SNEV at S149A is ATM‐dependent.
(A)  ATM  inhibition  alleviates  phosphorylation  of  SNEV  in
response to oxidative stress. HDFs were treated with 100 μM
H2O2  and  the  specific  ATM  inhibitor  KU‐55933.  DMSO,  the
solvent  for  Ku‐99533,  was  used  as  negative  control.
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as described earlier [26]. WtSNEV HUVEC did not enter 
apoptosis upon the treatment in accordance to our earlier 
results [26], which is also in agreement with findings by 
the Legerski lab, that GFP-SNEV overexpression in Hela 
cells reduces MMS induced apoptosis by two-fold [24]. 
In contrast, in SNEV S149A HUVEC the BSO/bleo-
mycin treatment clearly induced apoptosis/necrosis. The 
initially low level –when compared to empty vector 
control cells- of cell death of 10% for SNEV S149A 












































Since SNEV is required for repair of DNA interstrand 
cross-links [25], we tested if SNEV overexpression 
protected cells from the deleterious effects of the DNA 
cross-linking agent cisplatin. Figure 5E shows that 
cisplatin treatment very strongly induced apoptosis in  
empty vector control HUVEC as well as in SNEV 
S149A HUVEC, while wtSNEV HUVEC were clearly 
more resistant to this treatment. Therefore, we conclude 
that phosphorylation of SNEV at S149 is necessary for 













































Figure  5.  Phosphorylation  at  S149  is
necessary for apoptosis resistance and
partially  for  life  span  extension
conferred by SNEV. (A) Normal HUVEC as
well  as  stable  HUVEC  overexpressing  SNEV
wt, SNEV S149A or empty vector control cells
were  lysed  and  submitted  to  SDS  PAGE.
Western Blots were probed with anti‐SNEV
and  anti‐ßActin  antibodies.  SNEV  protein
expression  levels  are  increased  five‐fold  in
SNEV wt and ten‐fold in SNEV S149A HUVEC
as  compared  to  untransfected HUVEC.  (B)
Growth  curves  of  HUVEC  overexpressing
SNEV wt, SNEV S149A and empty vector. (C)
SNEV  wt  as  well  as  SNEV  S149A
overexpression  reduces  the  basal  level  of
DNA  damage.  Upper  panel:  Representative
pictures  of  Comet  assay  performed  with
empty  vector,  SNEV  wt  and  S149A  point
mutant overexpressing HUVEC. Lower panel:
Comets  were  classified  into  5  categories
depending  on  the  percentage  of  the  DNA
content  in  the  tail.  DNA  damage  levels  of
SNEV  S149A.  (D)  Cells  were  pre‐incubated
with  1  mM  BSO  for  48h,  followed  by
treatment  with  100  μg/ml  Bleomycin  for
24h.  Apoptosis  was  measured  by  Annexin‐
FITC  and  PI  staining  and  subsequent  flow
cytometric analysis. (E) Cells were incubated
with  100µg/ml  Cisplatin  for  24h.  Apoptosis
was measured as in D. 
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phosphorylation incompetent SNEV does have a small 
but discernible effect on the DNA damage status under 
normal culture conditions when compared to wtSNEV 
overexpression, but does not exert the strong anti-
apoptotic effect of wtSNEV after induction of DNA 
damage by either oxidative stress or interstrans 
crosslinks.  
 
In any case, the life-span extending and DNA repair 
functions of SNEV do partially depend on phospho-




Here, we present SNEV as a novel ATM-dependent 
phosphoryalation substrate in response to oxidative 
stress induced DNA damage. We show that SNEV is 
phosphorylated at S149 in an ATM-dependent manner 
in different cell types in response to various DNA 
damage. Surprisingly, ATM-dependent phosphorylation 
at S149 is essential for suppressing oxidative stress 
induced apoptosis, but dispensable for efficient DNA 
break repair and accounts for part of the cellular life 
span extension observed upon SNEV overexpression.  
A plethora of mutations in the DNA damage response 
pathways, specifically in transcription-coupled 
nucleotide excision repair (TC-NER) is known to be 
responsible for premature ageing syndromes in humans 
(reviewed in [35]) Accordingly, gene knock-outs of 
these factors also show premature aging in mice. 
However, to the best of our knowledge, only two 
studies have so far reported that DNA repair factors 
upon overexpression extend the life span of model 
systems. One example is overexpression of the repair 
factor GADD45 in the nervous system of D. 
melanogaster that increased the life span of these 
animals [36], while overexpression in the whole animal 
was lethal [37]. The other example is mice with single 
extra copies of the tumor suppressor p53 and its 
stabilizer Arf, which led to an extension of the median 
life span by 16% compared to controls, while the 
maximum life span was not increased [38].  
 
We have recently observed that a multi-talented protein, 
SNEV, extends the replicative life span of endothelial 
cells upon overexpression, reduces basal levels of DNA 
damage and suppresses oxidative stress induced 
apoptosis in these cells [39]. The multiple talents of 
SNEV, however, include a well documented function in 
DNA repair [23-25, 40], but also in pre-mRNA splicing, 
ubiquitination and proteasomal breakdown as well as 
adipogenic and neurogenic differentiation, where 
another phosphorylation sites plays a crucial role [28, 
29]. Therefore, it is not yet clear which function of 
SNEV is responsible for the life span extending activity. 
We here identified an ATM consensus phosphorylation 
site on SNEV. Our experimental design does not 
provide direct evidence that ATM phosphorylates 
SNEV at this site. However, SNEV’s highly conserved 
yeast homologue Prp19 is a direct phosphorylation 
target of Tel1 and/or Mec1, the yeast homologues of 
ATR and ATM [41], making it more likely that also in 
humans this direct link is conserved.  
 
Since ATM dependent phosphorylations are key signals 
of DNA damage and oxidative stress, we hypothesized 
that ATM dependent phosphorylation of SNEV might 
contribute to cellular life span extension as consequence 
of activating SNEV’s DNA repair activity. Therefore, 
we overexpressed the phosphorylation-incompetent 
point mutant versus wild type SNEV and found that the 
DNA damage status of cells in unstressed conditions 
overexpression is slightly but not dramatically reduced 
by the point mutation. Surprisingly, suppression of 
apoptosis upon oxidative stress treatment as seen upon 
SNEV overexpression was completely abolished by 
S149A mutation, suggesting an important role of ATM 
dependent phosphorylation of SNEV for induction of 
apoptosis. It is tempting to speculate that at least part of 
this high susceptibility of ATM deficient cells to 
apoptosis [13, 42, 43] is dependent on the inability to 
phosphorylate SNEV. Furthermore, the susceptibility of 
ATM deficient cells to undergo apoptosis is not only 
dependent on DNA damaging agents, but also on 
oxidative stress [44], well in accordance with our data.  
How might the S149 phosphorylatable form of SNEV 
suppress apoptosis? 
 
Phosphorylated SNEV localizes under basal conditions 
exclusively to the cytoplasm, but is detected 
predominantly in the nucleus after DNA damage. 
Although it is likely that ATM phosphorylation occurs 
in the nucleus, it cannot be ruled out that phosphoSNEV 
is imported into the nucleus. This would be supported 
by the notion that amino acids 1-166 of mouse SNEV 
are necessary for nuclear import [45] and the 
phosphorylation site lies within this portion possibly 
conferring a nuclear import signal. However, one report 
suggests that cytoplasmic SNEV is responsible to 
suppress apoptosis, at least under conditions of hypoxia. 
Under hypoxic conditions, a particular form of redox 
stress, SNEV is observed to interact with PHD3 in the 
cytoplasm [46], an interaction that suppresses cell 
death. In addition, GFP-SNEV, which locates 
preferentially in the cytoplasm (compared to untagged 
SNEV), has a stronger anti-apoptotic effect than 
untagged SNEV, indicating the cytoplasmic localization  
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find that upon overexpression, the cytoplasmic portion 
of SNEV is increased when compared to untransfected 
HUVEC (See Fig. S3), backing up the importance of 
cytoplasmic SNEV in preventing apoptosis. On the 
other hand, also in SNEV S149A HUVEC, the ratio of 
nuclear versus cytoplasmic SNEV is shifted towards the 
cytoplasm in a manner similar to SNEV wt HUVEC, 
but still these cells undergo apotosis upon oxidative 
stress, indicating that the phosphorylatability of 
cytoplasmic SNEV is essential for its anti-apoptotic 
effect. Under normoxic conditions, SNEV interacts with 
PHD3 via its C-terminus, while under hypoxic 
conditions, a hypoxia inducible interaction domain 
comprising amino acids 66-220 stabilizes this 
interaction [46]. Since this region covers the S149, it is 
tempting to speculate that ATM-dependent 
phosphorylation at S149 is the signal for increased 
binding to PHD3, leading to apoptosis suppression, 
while the non-phosphorylatable S149A mutant binds 
PHD3 with lower affinity, allowing for caspase 
activation by PHD3. It is also unclear, how the 
phosphoSNEV would accumulate in the cytoplasm, as it 
is not detected there upon stress with our antibody. It 
will be interesting to see if a phospho-mimicking 
S149D point mutant further increases the anti-apoptotic 
effect of SNEV overexpression and where it will 
localize.  
 
The finding that the point mutant only slightly improves 
the basal DNA damage status of the cells as visualized 
by comet assays suggests that the here identified 
phosphorylation site might be decoupling the DNA 
repair activity from the apoptosis signalling activity of 
SNEV.  
 
It remains to be elucidated how this translates into the 
extended life span of SNEV overexpressing cells. 
Suppression of apoptosis might reduce the loss of cells 
during cultivation and thus increase the total replicative 
life span merely by reducing the replicative exhaustion 
of the cells. However, the apoptosis competent cells of 
the S149A mutant overexpression are still markedly 
longer lived than empty vector controls. This would 
suggest that the full life span extension as observed by 
wtSNEV overexpression depends on both, apoptosis 
suppression and the lower basal DNA damage of the 
cells and thus on SNEV’s DNA repair activity. 
 
Taken together, our data support the hypothesis that 
DNA damage repair and signalling factors can extend 
the life span of model systems, as in this case the 
replicative life span of endothelial cels and thus support 
the idea that a genetically programmed DNA repair 
ability counteracts and slows down the stochastic 





Cells and culture conditions. HeLa cells were grown in 
RPMI1640 (Biochrom AG, Berlin, Germany) 
supplemented with 10% fetal calf serum (FCS).  
Human diploid fibroblasts (HDF) were grown in 
DMEM/HAM’s F12 1:2 (Biochrom AG, Berlin, 
Germany) supplemented with 10%FCS.  
Human umbilical vein endothelial cells (HUVEC) were 
cultivated in EBM Basal Medium plus EGM 
SingleQuot Supplements & Growth Factors (Lonza, 
Basel, Switzerland) supplemented with FCS to a final 
10%. For HUVEC, flasks were precoated with 0.1% 
gelatine in PBS. 
GFP-SNEV-Hela were established by transfecting Hela 
cells with a SNEV-BAC construct  containing all 
regulatory elements obtained from Ina Poser, Max 
Planck Institute for Molecular Cell Biology and 
Genetics, Dresden, Germany. GFP-SNEV-Hela were 
cultivated in RPMI1640 (Biochrom AG, Berlin, 
Germany) supplemented with 10% fetal calf serum 
(FCS) and 800 µg/ml G418 (Gibco, now life 
technologies, Grand Island, NY, USA). 
Confluent adherent cultures were detached using 0.1% 
trypsin and 0.02% EDTA and were passaged with an 
appropriate split ratio of 1:2 or 1:4 once or twice a week 
depending on confluence and population doubling level 
(PD). Subsequently, cumulative PDs were calculated as 
a function of passage number and split ratio [47]. 
Fibroblasts (HDF5) 2x10
5 /well were seeded in 6 well 
plates. The next day, cells were treated with H2O2 (100, 
200, 400 µM/ml) for 1 hour and 100  µM/ml for 
different time spans (5, 15, 30, 60, 120 minutes). 
Fibroblasts (HDF5) were seeded in 6 well plate at a 
density of 2x10
5  cells/well 24 hours before treatment 
with 2.5, 5, 10, 25, 50, 100 µg/ml of Bleomycin for 1 
hour and 25µg/ml for (5,15,30,60,120 minutes). For 
Mitomycin C treatment, fibroblasts cells were exposed 
to different concentration (2.5, 5, 10, 25, 50 µg/ml) for 
24 hours. Cell were scraped directly on ice in 2x SDS 
loading dye, sonicated and boiled. Proteins were 
separated by SDS gel electrophoresis in 4-12% BT gel 
(Invitrogen, now life technologies, Grand Island, NY, 
USA). 
To induce apoptosis, cells were seeded into 12-well cell 
culture plates at a density of 10000 cells /cm
2. To 
enhance the sensitivity of cells to bleomycin-induced 
apoptosis, cells were cultivated in the presence of 1 mM 
buthionine-sulfoximine (BSO, Sigma-Aldrich, St.Louis, 
MO, USA) for 48 h before treatment with with 100 
μg/ml of bleomycin (Sigma-Aldrich, St.Louis, MO, 
USA) for further 24 h. Alternatively, cells were treated 
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apoptosis induction by DNA cross-links. 
 
ATM deletion in mouse embryonic fibroblasts. Primary 
mouse embryonic fibroblasts (MEF) were prepared 
from E13.5 fetuses (ATM
flox/flox). Cells were cultured in 
DMEM high glucose medium (Sigma-Aldrich) 
supplemented with 15% fetal bovine serum (Lonza), 1% 
L-glutamine (Gibco, now life technologies, Grand 
Island, NY, USA), 1% penicillin and strepromycin, 1% 
NEAA (non essential amino acids, Gibco), 1% sodium 
pyruvate (Gibco) and β-mercaptoethanol (1:140000). 
Large T-Antigen was used to immortalize MEFs 
(ATM
flox/flox). For the generation of retrovirus, Large T-
Antigen -MSCVneo plasmid was co-transfected with 
the packaging plasmid pCL-Eco and the enveloping 
plasmid VSV-G in 293T cells. Supernatant was 
collected after 24 and 48 hours. MEFs were transduced 
using 5 ml of filtered supernatant added to 5 ml cell 
culture medium in the presence of 8 mg/ml polybrene 
(Sigma-Aldrich). After 24 hours virus was removed. 14 
days selection was started 72 hours after infection using 
400µg/ml neomycin (Sigma-Aldrich). 
In a second infection step, Large T-Antigen-
immortalized MEFs were transduced with the Cre-
pBabe-puro retrovirus for the Cre-mediated deletion of 
ATM. Selection was started 72 hours after transduction 
with 2 µg/ml puromycin for 7 days. Medium was 
exchanged every Deletion of ATM was verified by PCR 
of genomic DNA using primer 1 (5’ ATC AAA TGT 
AAA GGC GGC TTC 3’), primer 2 (5’CAT CCT TTA 
ATG TGC CTC CCT TCG CC 3’) and primer 3 
(5’GCC CAT CCC GTC CAC AAT ATC TCT GC 3’) 
giving rise to three fragments representing absence or 
presence of loxP sites or deletion of ATM. 
 
Plasmid construction, generation of recombinant 
retroviruses and cell line establishment. SNEV cDNA 
was amplified by PCR and ligated into the retroviral 
plasmid pLenti6. The SNEV S149A point mutant was 
generated using the QuikChange Multi Site-Directed 
Mutagenesis Kit (Agilent, Santa Clara, CA, USA). The 
negative control vector contained only the blasticidin 
resistance gene. Retroviral particles were generated 
according to the manufacturer's protocol (Invitrogen). 
For cell line establishment, HUVECs (PD14) were 
infected with retroviral particles according to the 
manufacturer's protocol (Invitrogen, now life 
technologies, Grand Island, NY, USA) at a multiplicity 
of infection (MOI) of 4 in EBM with 10% FCS 
supplemented with 8 μg/ml Polybrene. Thereafter, 
transfectants were selected using 5 μg/ml Blasticidin. 
Arising cell clones (similar number in all experiments) 
were grown as mass culture. PDs post transfection (pT) 
were calculated starting with the first passage after 
selection was completed. 
 
Antibodies. Prp19/Pso4 rabbit polyclonal antibody was 
from Bethyl Laboratories (Montgomery, TX, USA) 
#A300-102A.  ATM antibody [2C1] mouse monoclonal 
antibody was from Gene Tex (Irvina, CA, USA) # 
GTX70103.  anti-pSNEV(S149) rabbit polyclonal 
antibody was generated by Moravian Biotechnology 
Ltd. (Bratislava, Slovakia). Gamma H2A.X (phospho 
S139) mouse monoclonal antibody [9F3] was from 
Abcam (Cambridge, UK) #26350. ß-Actin mouse 
monoclonal antibody was from Sigma-Aldrich 
(St.Louis, MO, USA) #A-5441. GAPDH rabbit 
antibody FL-335 was from Santa Cruz (Santa Cruz, CA, 
USA) #sc-25778. 
 
SDS PAGE and Western Blotting.  For SDS PAGE, 
protein samples were mixed with 4x SDS loading dye 
(240 mTris-Cl    pH 6.8, 8% SDS, 40 % glycerol, 0.05 
% bromophenol blue, 5% ß-Mercaptoethanol) and 
heated to 75°C for 10min. Samples were separated on a 
NuPAGE 4–12% Bis/Tris polyacrylamide gel 
(Invitrogen, Carlsbad, CA; USA) in MOPS buffer at 
200V. Electrophoresis and blotting to PVDF membrane 
(Roth, Karlsruhe, Germany) were performed using the 
XCell  SureLock®  Mini-Cell (Invitrogen, now life 
technologies, Grand Island, NY, USA) in accordance to 
the manufacturer's protocol. After incubating with 
blocking buffer (3% skim milk powder in PBS with 
0.1% Tween-20) on an orbital for 1h at room 
temperature or overnight at 4°C, the membranes were 
incubated for 1h or overnight with the primary antibody 
diluted in blocking buffer, followed by 1h incubation 
with secondary anti-Rabbit-IR-Dye 800 and/or anti-
Mouse-Alexa 680 (Licor), both diluted 1:10000 in 
blocking buffer. Both antibody incubations were 
followed by 3 washes with PBS with 0.1% Tween-20. 
Membranes were scanned using the Odyssey infrared 
imaging system (LI-COR, Lincoln, NE, USA). Mouse 
anti-ßActin (Sigma-Aldrich, St.Louis, MO, USA) or 
rabbit anti-GAPDH (Santa Cruz, Santa Cruz, CA, USA) 
were used as loading controls. 
 
Dephosphorylation.  For dephosphorylation experi-
ments, H2O2 treated or untreated HeLa cells were 
harvested by trypsinization, collected by centrifugation 
at 170g for 10 min, washed twice with PBS and 
resuspended in NEB3 Buffer (New England Biolabs, 
Ipswich, MA, USA), in which Calf intestinal 
phosphatase (CIP; New England Biolabs, Ipswich, MA, 
USA) has optimal activity. Cells were lysed by 
sonication and subsequent centrifugation at maximum 
speed for 30 min at 4°C. Cleared lysates were split and  
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37°C, whereas the other half was mock treated. 
Subsequently, samples were submitted to Western Blot 
analysis. 
 
Anti-GFP Trap IP.  GFP-SNEV-Hela were grown to 
90% confluence in T175 roux flask and incubated with 
100 µM H2O2 to induce SNEV phosphorylation or left 
untreated as negative control. Cells were scraped on ice 
in 3ml Lysis buffer ( 50 mM Hepes-KOH pH 7.5, 5 mM 
EDTA pH8, 150 mM KCl, 10% glycerol, 1% Triton X-
100, 20 mM ß-glycerophosphate, 10mM Na-
pyrophosphate, 10 mM NaF, 1 mM DTT, 1 mM 
Na3VO4, 0.1mM PMSF, 20 µg/ml Leupeptin, 20 µg/ml 
Chymostatin, 20 µg/ml Pepstatin, 1µM Okadaic acid) 
per T175 and sonicated using 3 bursts of 10s. Lysate 
was cleared by centrifugation for 30 min at full speed. 
All centrifugation stepy were carried out at 4°C. 30 µl 
GFP-Trap Beads (ChromoTek, Munich, Germany) were 
equilibrated by washing thrice in 500 µl ice cold wash 
buffer (50mM Hepes-KOH pH 7.5, 5mM EDTA pH8, 
150mM KCl, 10% glycerol, 0.05% NP-40, 20 mM ß-
glycerophosphate, 10 mM Na-pyrophosphate, 10mM 
NaF, 20 µg/ml Leupeptin, 20 µg/ml Chymostatin, 20 
µg/ml Pepstatin) and collected by centrifugation at 
2,700 x g for 2 min. 1 ml Lysate corresponding to 1 mg 
total protein was added to the beads mixed on an 
overhead shaker for 1h at 4°C. Beads were collected by 
centrifugation for 2 minutes at 2,000 x g. Discard 
supernatant and wash beads 5x times with 500µL ice 
cold wash buffer (ocadaic acid added only for the first 
two washing steps) and finally resuspended in washing 
buffer. 
 
Mass spectrometric analysis. Beads were washed five 
times with ammonium bicarbonate buffer (50mM 
ABC). Disulfide bonds were reduced by incubation with 
dithiothreitol (DTT, 5% w/w of the estimated amount of 
protein) for 30 min at 56°C and Cys-residues were 
subsequently alkylated with iododacetamide (IAA, 25% 
w/w of the estimated amount of protein) for 20 min at 
RT in the dark. DTT (2.5% w/w of the estimated 
amount of protein) was added to consume excess IAA 
and proteins were digested with subtilisin for 1 hour at 
37°C. Digests were stopped by addition of trifluoro 
acetic acid (TFA) to approx. pH 3. 10% of the peptide 
mixture was analysed directly, the remaining 90% were 
enriched for phosphopeptides by the use of TiO2 as 
described in [48]. Peptides were separated on a U3000-
HPLC-system (Dionex, Sunnyvale, CA, USA). Peptides 
were loaded on to a the trapping column (PepMAP C18, 
0.3 × 5 mm, Dionex) with 0.1 % TFA as loading solvent 
and then eluted onto an analytical column (PepMAP 
C18, 75 μm × 150 mm, Dionex) with a flow rate of 300 
nl/min and a gradient from 0 % solvent B to 100 % 
solvent B in 90 min, followed by a washing step of 10 
min with 10 % solvent B  and 90 % solvent C (solvent 
B: 40 % acetonitril (ANC), 0.08 % formic acid, solvent 
C: 80% ACN, 10% trifluorethanol, 0.08 % formic acid). 
The HPLC system is online coupled to a Velos Orbitrap 
mass spectrometer (Thermo Scientific, Waltham, MA, 
USA) equipped with an ESI-source (Proxeon, now 
Thermo Scientific). A full scan (scan range 400-1800 
Th, resolution 60.000) was followed by MS2 analysis 
by collision-induced dissociation (CID) of the 20 most 
intense precursors in the linear iontrap. Normalized 
collision energy was set to 35%, activation Q at 25 and 
activation time at 30 ms. Peptide identification was 
performed using the SEQUEST algorithm in the 
ProteomeDiscoverer 1.3.0.339 software package 
(Thermo Scientific). Carbamidomethylation of Cys was 
set as static modifications, phosphorylation of 
Ser/Thr/Tyr and oxidation of Met were set as variable 
modifications. Spectra were searched against a small 
database plus contaminants for a fast PTM analysis. 
Search parameters were no protease specificity, a 
peptide tolerance of 2 ppm, a fragment ions tolerance of 
0.8 Da. The results were filtered at the XCorr values to 
an FDR of 1% on the peptide level. The probability of 
phosphosite localization was calculated using the 
phosphoRS 2.0 software [49] implemented into the 
Proteome Discoverer.  
 
Indirect immunofuorescence staining. Cells were seeded 
on coverslips one day prior to immunofluorescence 
staining. The next day, cells were washed with PBS and 
fixed with 3.7% (w/v) for 20 min at room temperature. 
Permeabilization
  was performed with 0.1% Triton X-
100 in PBS for 10 min at room temperature. Cells were 
incubated with primary antibodies diluted in PBS with
 
10% FCS for 1 h, washed 3 times for 10 min with
 PBS, 
incubated for 1 h with the appropriate secondary
 
antibodies diluted in PBS with 10% FCS, and washed 3 
times
 for 10 min with PBS. Anti-pSNEV (S149) was 
diluted 1:250. As secondary antibodies, anti mouse 
dyelight488 1:1000 and dyelight649 1:1000 anti-rabbit 
or anti-mouse antibodies were used.  Microscope as 
described previously. 
To visualize the nuclei, cells were counterstained with 
4',6-diamidino-2-phenylindole (DAPI). Cells were 
washed and fixed as above and subsequently incubated 
with 100ng/ml DAPI in PBS for 10 min at room 
temperature. 
After staining, slides were mounted on cover slips using 
slow fade gold Mounting Medium for Fluorescence (life 
technologie, Grand Island, NY, USA) and sealed with 
nail polish. 
Microscopy
 and image analysis were carried out using a 
Leica SP5 II laser scanning confocal microscope (Leica 
Microsystems CMS, Mannheim, Germany). 
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damage in SNEVwt and SNEV S149A overexpressing 
HUVEC under basal conditions was measured by 
single-cell gel electrophoresis (comet assay) under 
alkaline conditions as described previously [50]. At 
least 100 randomly selected cells per slide were 
examined for the presence or absence of comets using 
fluorescence microscopy. The cells were assigned to 
five different categories according to their DNA content 
in tail using the TriTek CometScore software. 
Percentage of cells in each category was calculated. 
 
Apoptosis staining.  Cells were detached using 0.1% 
Trypsin/0,02%EDTA and stained with Annexin V–
Bacific Blue (Invitrogen, now life technologies) and PI 
(Roche, Basel, Switzerland) according to the 
manufacturer's instructions. Analysis of the percentages 
of apoptotic and necrotic/late-apoptotic cells was 
performed using a BD FACS Canto II flow cytometer 
(Becton Dickinson, Franklin Lakes, NJ, USA) and the 
FCS Express V3 software (De Novo Software, Los 
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